NCT03230318 · Interventional trial
Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma
Overall registry status Completed
Phase 2
Conditions Combined Hepatocellular and Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory